The documents in this section are currently being reviewed and remediated into an accessible format. If the document you require, is not available, please contact Prescribing Partnership for a copy.
Attention Deficiency Hyperactive Disorder in Children and Young People
Alemtuzumab for relapsing-remitting multiple sclerosis
Apomorphine use in Parkinsons disease
Azathioprine & 6-mercaptopurine treatment for paediatric gastroenterology and hepatology patients
Azathioprine Adults for inflammatory conditions
Bosentan for digital ulcers in systemic sclerosis
Ciclosporin for inflammatory diseases
Cinacalcet for primary Hyperparathyroidism
Cinacalcet for the management of secondary hyperparathyroidism NWAFT
Dapsone - Dermatitis Herpetiformis and other Dermatose
Dexamfetamine Excessive sleepiness associated with narcolepsy
Gentamicin for Nebulisation (PAPWORTH)
Humulin R U500 Insulin for patients with severe insulin resistance
Leflunomide in rheumatic diseases
Mercaptopurine for Inflammatory bowel disease
Methylphenidate - excessive sleepiness associated with narcolepsy
Midodrine for orthostatic hypertension and neurocardiogenic syncope
Modafinil for narcolepsy - Papworth
Mycophenolate mofetil (MMF) use in multisystem autoimmune disease
Nintedanib for idiopathic pulmonary fibrosis
Penicillamine (Wilsons disease)
Pirfenidone for idiopathic pulmonary fibrosis
Riluzole for amyotrophic lateral sclerosis form of MND
Sulfasalazine in rheumatic diseases
Tolvaptan for autosomal dominant polycystic kidney disease
Triptorelin 4 weekly administration/ 12 weekly administration - Precocious Puberty